Skip to main navigation Skip to search Skip to main content

Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation

  • Aubrianna S. Ramsland
  • , Karolina Dudek
  • , Kelsey E. McNeely
  • , Joseph M. Cannova
  • , Zahra Khosravi
  • , Jonathan Burnett
  • , Yoav Gilad
  • , Lucy A. Godley
  • , Elizabeth A. Griffiths
  • , Michael W. Drazer
  • The University of Chicago
  • Northwestern University

Research output: Contribution to journalArticlepeer-review

Abstract

Thrombocytopenia 2 (OMIM 610855) is a hereditary thrombocytopenia and blood cancer syndrome caused by germline mutations in the 5′ untranslated region of ANKRD26. We generated an induced pluripotent stem cell (iPSC) line (CGOi001-A) from a donor with a germline ANKRD26 mutation and hereditary thrombocytopenia. This line is a valuable resource for studying the ANKRD26-mutant cellular phenotype.

Original languageEnglish
Article number103919
JournalStem Cell Research
Volume91
DOIs
StatePublished - Mar 2026

Fingerprint

Dive into the research topics of 'Generation of an induced pluripotent stem cell line CGOi001-A from a patient with hereditary thrombocytopenia and a germline ANKRD26 mutation'. Together they form a unique fingerprint.

Cite this